TSHA Taysha Gene Therapies PE ratio, current and historical analysis

The current PE ratio of TSHA cannot be calculated, as the latest EPS of -$0.34 is negative. The most recent PE ratio recorded for Taysha Gene Therapies was 3.19 in September 2024.

TSHA PE ratio history

How has TSHA's PE ratio performed in the past

Today

N/A

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Taysha Gene Therapies PE ratio by year

Year	PE ratio	PE change	Price	EPS
2024	N/A	N/A	$1.73	-$0.36
2023	N/A	N/A	$1.77	-$0.96
2022	N/A	N/A	$2.26	-$3.78
2021	N/A	N/A	$11.65	-$4.64
2020	N/A	N/A	$26.54	-$3.4

Taysha Gene Therapies PE ratio by quarter (TTM)

Year	PE ratio	PE change	Price	EPS
Mar 2025	N/A	N/A	$1.39	-$0.34
Dec 2024	N/A	N/A	$1.73	-$0.36
Sep 2024	3.19	N/A	$2.01	$0.63
Jun 2024	N/A	N/A	$2.24	-$0.2
Mar 2024	N/A	N/A	$2.87	-$0.49
Dec 2023	N/A	N/A	$1.77	-$0.96
Sep 2023	N/A	N/A	$3.16	-$2.58
Jun 2023	N/A	N/A	$0.66	-$2.3
Mar 2023	N/A	N/A	$0.8	-$2.77
Dec 2022	N/A	N/A	$2.26	-$3.78
Sep 2022	N/A	N/A	$1.93	-$4.15
Jun 2022	N/A	N/A	$3.72	-$4.85
Mar 2022	N/A	N/A	$6.52	-$5.09
Dec 2021	N/A	N/A	$11.65	-$4.64
Sep 2021	N/A	N/A	$18.62	-$2.98

TSHA Price vs fair value

How does TSHA's price compare to its estimated fair value based on its growth

TSHA average PE ratio chart

What is the average PE ratio of TSHA for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

TSHA PE vs peers

What is TSHA's PE ratio compared to its peers

Stock name	PE ratio	Market cap
OLMA Olema Pharmaceuticals Inc	N/A	$296.95M
OMER Omeros Corp	N/A	$202.73M
VIVS VivoSim Labs Inc.	N/A	$2.65M
ORIC Oric Pharmaceuticals Inc	N/A	$676.76M
ORMP Oramed Pharmaceuticals Inc	N/A	$87.83M
TSHA Taysha Gene Therapies Inc	N/A	$637.55M

Frequently asked questions

What is Taysha Gene Therapies's PE ratio?

The current price to earnings ratio of TSHA cannot be determined, as its EPS of -$0.34 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.